First New York Securities’s Novartis NVS Stock Holding History

First New York Securities’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-25,110	Closed	-$2.07M	–	194
2015 Q3	$2.07M	Sell	25,110 -3,348	-12%	-$298K	0.93%	24
2015 Q2	$2.51M	Buy	28,458 +22,878	+410%	+$2.1M	1.26%	19
2015 Q1	$493K	Buy	+5,580	New	+$495K	0.49%	29
2014 Q2	–	Sell	-9,263	Closed	-$706K	–	303
2014 Q1	$706K	Buy	+9,263	New	+$675K	0.35%	73
2013 Q3	–	Sell	-5,580	Closed	-$354K	–	440
2013 Q2	$354K	Buy	+5,580	New	+$363K	0.13%	125

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Institutional Capital Chicago, Illinois $6.75B AUM 3.51% 1-Year Est. Return

First New York Securities's NVS Position: Q4 2015 in Review

First New York Securities sold out of Novartis (NVS) in Q4 2015, closing a stake of 25,110 shares — an estimated $2.07M sold.

First New York Securities first reported a position in NVS in Q2 2013 and held it in 5 quarters. The position peaked at $2.51M in Q2 2015. 927 funds tracked by Wall St. Rank hold NVS as of Q4 2015.

First New York Securities reported no remaining Novartis position as of Q4 2015 after selling out during the quarter.
First New York Securities sold 25,110 Novartis shares in Q4 2015, an estimated $2.07M.
First New York Securities first reported a position in Novartis in Q2 2013 and held it in 5 quarters.
First New York Securities's Novartis position peaked at $2.51M in Q2 2015.
927 funds tracked by Wall St. Rank held Novartis as of Q4 2015.

Based on First New York Securities's 13F filing for Q4 2015, filed 25 Jan 2016.